Reaction

Spirometry Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 580 reports · 82 co-occurring drugs

As of the last recalculation, Spirometry Abnormal appears in 580 FAERS reports alongside 82 co-occurring drug terms. The strongest observed disproportionality signal is DUTASTERIDE (PRR 2,421.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dutasteride	282	2,421.3	2,508.8
Ciclesonide	317	1,840.7	1,884.8
Moxifloxacin Hydrochloride	286	997.7	1,012.1
Moxifloxacin	172	622.5	630.2
Doxazosin Mesylate	285	556.0	560.4
Drs. Clotrimazole	109	416.5	420.5
Family Wellness Clotrimazole	109	416.5	420.5
Clotrimazole Topical	109	416.3	420.3
Cefuroxime	104	397.6	401.2
Clotrimazole	109	391.9	395.5
Budesonide	295	364.6	366.5
Fluticasone Propionate And Salmeterol Xinafoate	281	324.8	326.3
Levofloxacin	262	283.5	284.8
Levofloxacin In 5% Dextrose	262	283.5	284.8
Escitalopram Oxalate	286	276.7	277.8
Doxazosin	143	243.1	244.3
Diltiazem Hydrochloride Extended-Release Tablets	68	242.8	244.3
Cephalexin	114	235.0	236.3
Rosuvastatin Calcium	139	232.6	233.7
Diltiazem Hydrochloride	161	230.8	231.9
Insulin Glargine-Yfgn	100	198.1	199.0
Tiotropium Bromide	323	189.7	190.2
Magnesium Oxide	150	173.2	173.8
Mepolizumab	163	163.3	163.9
Albuterol	273	153.3	153.7
Candesartan	120	152.0	152.5
Tamsulosin Hydrochloride	73	146.7	147.2
Umeclidinium Bromide And Vilanterol Trifenatate	61	146.3	146.9
Escitalopram	288	145.3	145.6
Antacid	139	137.8	138.2
Sennosides	91	129.4	129.8
Salmeterol Xinafoate	27	117.9	118.2
Mometasone	54	116.4	116.7
Bisacodyl Suppositories	39	115.9	116.2
Biscodyl	39	114.8	115.2
Calcium Carbonate	154	111.7	111.9
Azithromycin	102	110.2	110.4
Bisacodyl	40	109.5	109.8
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	103	108.3	108.5
Azithromycin Monohydrate	102	106.4	106.7
Candesartan Cilexetil	68	105.0	105.3
Escitslopram	130	103.1	103.3
Apixaban	141	99.6	99.8
Amoxicillin And Clavulanate Potassium	65	96.5	96.8
Albuterol Sulfate	336	95.2	95.3
Azithromycin Dihydrate	119	91.3	91.5
Senna Leaf	52	88.8	89.0
Liraglutide	101	88.6	88.8
Fluticasone Furoate And Vilanterol Trifenatate	69	78.0	78.2
Montelukast	126	68.5	68.6
Montelukast Sodium	163	66.4	66.5
Trimethoprim	21	66.3	66.4
Thiamine Hydrochloride	22	65.9	66.0
Azathioprine	125	64.6	64.7
Alendronate Sodium	134	61.7	61.8
Pantoprazole Sodium In 0.9% Sodium Chloride	87	59.1	59.2
Pantoprazole Sodium Injection	87	59.1	59.1
Mometasone Furoate	56	53.3	53.3
Insulin Aspart	78	48.8	48.8
Omalizumab	95	47.6	47.7
Senna	26	46.3	46.4
Metformin Hydrochloride Tablets	65	45.7	45.7
Metformin Hydrochloride Extended-Release Tablets	65	45.7	45.7
Metformin Hydrochloride Tablet	65	45.7	45.7
Sennosides 8.6 Mg Tablets	25	44.7	44.7
Metformin Hydrochloride	65	44.3	44.3
Alendronate Sodium Tablet	19	38.0	38.0
Levothyroxine Sodium Anhydrous	89	37.5	37.5
Tiotropium Bromide Inhalation Spray	11	35.9	35.9
Sulfamethoxazole And Trimethoprim	70	33.7	33.8
Fluticasone Furoate	11	33.2	33.2
Amoxicillin	61	31.9	31.9
Rosuvastatin	139	31.7	31.8
Fluticasone Propionate Nasal	24	29.6	29.6
Carbamazepine	48	27.9	28.0
Dorzolamide Hydrochloride And Timolol Maleate	6	27.5	27.5
Rocuronium Bromide	8	24.7	24.7
Umeclidinium	5	20.2	20.2
Pioglitazone	23	19.8	19.8
Insulin Glargine	111	19.7	19.7
Dornase Alfa	10	18.6	18.6
Benralizumab	8	14.5	14.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.